Butacaine

306.44

306.44

205-734-7

Z84S23CGJJ

758632

DTXSID3045300

2922499990

55.6

4.29910

1.0593 (rough estimate)

<25 °C

180 °C

219.9ºC

1.5700 (estimate)

>46 [ug/mL]

−20°C

6.1E-08mmHg at 25°C

Subcutaneous-rat LDL0: 150 mg/kg; subcutaneous-mouse LDL0: 100 mg/kg

Flammable; burning produces toxic nitrogen oxide gas

179 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

III

6.1(b)

3249

3

UB0875000

Treasury is ventilated, low temperature and dry; stored separately from food materials

highly toxic

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)

3-(dibutylamino)propyl 4-aminobenzoate

Pharmaceuticals